Back to discover
Drug

Thioctic Acid

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as (+)-alpha-Lipoic acid, (R)-(+)-Lipoate, .ALPHA.-LIPOIC ACID, ALPHA LIPOIC ACID+14 more

(+)-alpha-Lipoic acid, (R)-(+)-Lipoate, .ALPHA.-LIPOIC ACID, ALPHA LIPOIC ACID, ALPHA-LIPOIC ACID, Alphalipoic acid, D-thioctic acid, Lipoic Acid, Q-Gel with Lipoic Acid, R-(+)-thioctic acid, R-alpha-lipoic acid, Thioctic acid D-form, alpha-Liponsäure, (R)-1,2-Dithiolane-3-pentanoic acid, (R)-1,2-dithiolane-3-valeric acid, (R)-6,8-thioctic acid, .ALPHA.-LIPOIC ACID, (+/-)-, 1,2-dithiolane-3-pentanoic acid.

3
Research papers
10
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men With Obesity

Clinical trial2026-07-10Results expected Q1 2030 · ClinicalTrials.gov

The Effect of Alpha Lipoic Acid on the Clinical Outcome of Advanced Non-Small Cell Lung Cancer Patients

Clinical trial2026-05-08Results expected Q1 2027 · ClinicalTrials.gov

Evaluation of Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity in Oncology Patients

Clinical trial2026-05-04Results expected Q1 2027 · ClinicalTrials.gov

The Effect of Lipoic Acid Natural Supplement on Cystine Stone Formation

Clinical trial2026-04-15Results posted · ClinicalTrials.gov

Effect of Alpha Lipoic Acid on the Clinical Outcome of Pediatric Patients Undergoing Hemodialysis

Clinical trial2026-03-02Results expected Q4 2027 · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Thioctic Acid
Aliases & brands
(+)-alpha-Lipoic acid(R)-(+)-Lipoate.ALPHA.-LIPOIC ACIDALPHA LIPOIC ACIDALPHA-LIPOIC ACIDAlphalipoic acidD-thioctic acidLipoic AcidQ-Gel with Lipoic AcidR-(+)-thioctic acidR-alpha-lipoic acidThioctic acid D-formalpha-Liponsäure(R)-1,2-Dithiolane-3-pentanoic acid(R)-1,2-dithiolane-3-valeric acid(R)-6,8-thioctic acid.ALPHA.-LIPOIC ACID, (+/-)-1,2-dithiolane-3-pentanoic acid
RxNorm CUI
6417
ChEMBL ID
CHEMBL33864
ATC codes
A16AX01
UNII
73Y7P0K73Y

Clinical trials

78 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
78
registered trials across all phases
LATEST COMPLETION 2025
10
Active studies
8
Recruiting
47
Late-stage (III+)
48
Completed
20
Discontinued
PHASE DISTRIBUTIONn = 78
Early Phase 12Phase 14Phase 1 / 25Phase 220Phase 2 / 37Phase 313Phase 418Phase N / A9

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

3 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20112024
Major research themes5
Diabetes Mellitus1Insulin Resistance1Non-alcoholic Fatty Liver Disease1Polycystic Ovary Syndrome1Thioctic Acid1
Journals, researchers & institutions
Top journals
  • Current research in pharmacology and drug discovery1
  • Diabetes care1
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology1
Leading researchers
  • Aio C1
  • Basile GA1
  • Battipaglia C1
  • Boulton AJ1
  • Bruno A1
  • Campolo D1
  • Di Benedetto A1
  • Dyck PJ1
Leading institutions
free-text, unnormalised
  • Gynecological Endocrinology Center1
  • Institute for Clinical Diabetology1
  • Polyclinic Hospital University of Messina1
  • University of Messina1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 6 of the same disease areas as Thioctic Acid in the shared literature.

6 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials